Gene augmentation trials using the Rpe65-deficient dog: contributions towards development and refinement of human clinical trials. (2012)
Attributed to:
Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4614-0631-0_24
PubMed Identifier: 22183331
Publication URI: http://europepmc.org/abstract/MED/22183331
Type: Journal Article/Review
Volume: 723
Parent Publication: Advances in experimental medicine and biology
ISSN: 0065-2598